Studies

CellWell record HH-435709

Mesoporous silica nanoparticles functionalized with folic acid and zinc for enhanced targeted delivery of daunorubicin to breast cancer cells

Seyedeh Elaheh Sheykholeslami; Nasim Kaveh Farsani; Yeganeh Azari Incheh Sablagh; Soheil Afshari-BehbahaniZadeh; Mohammadhosein Keshvadi; Fatemeh Najafi; Hassan Noorbazargan

2026

In plain language

In MCF-7 breast cancer cells, folic-acid-coated silica nanoparticles carrying a chemotherapy drug and zinc produced a stronger cell-killing response than the free drug, with no effect on non-tumor MCF-10A cells, and raised BAX and caspase-9 while lowering BCL-2.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-435709

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.